PTC India said it has signed an agreement with Brookfield Renewables for purchase of 100 MW solar power on a long term basis. Below is a summary of how these 9 analysts rated PTC Therapeutics. These 9 analysts have an average price target of $58.0 versus the current price of PTC Therapeutics at $55.545, implying upside. Since publishing the last article on PTC Therapeutics, the company's share price has risen 31.28%, outperforming the iShares Biotechnology ETF and the S&P 500.ET by Jaimy Lee PTC Therapeutics stock price target cut to $63 from.1 day ago PTC Therapeutics shares fall 10% after announcing pause in U.S. Major Holders Insider Roster Insider Transactions. (PTC) NasdaqGS - NasdaqGS Real Time Price. The stock’s fifty day moving average price is $49.28 and its.PTC Inc. PTC Therapeutics has a one year low of $25.01 and a one year high of $56.72. PTC Therapeutics stock opened at $55.55 on Monday.
Dfind finance software#
is a global software company, which engages in the provision of portfolio of innovative digital solutions that work together to transform how physical products are engineered. Power trading solutions provider …PTC, Inc. (PTC).PTC India said it has signed an agreement with Brookfield Renewables for purchase of 100 MW solar power on a long term basis. Find out the direct holders, institutional holders and mutual fund holders for PTC Inc. PTC's stock has slipped 5.3% year to date and Rockwell shares, which rose 0.6% in midday trading, have tumbled 38.5% this year, while the S&P 500 SPX, -0.38% has dropped 14.5%.
0 kommentar(er)
